In primary TTP, there is no underlying predisposing condition. By contrast, secondary TTP is associated with another clinical diagnosis or underlying cause. In both cases, ADAMTS13 […]
Immune TTP
In this Podcast: A 42-year-old pregnant woman presents with thrombotic thrombocytopenic purpura ( TTP). She refuses plasma exchange because of her faith as a Jehovah’s Witness. […]
[…] Caplacizumab-yhdp (Cablivi) was FDA approved in 2019 for treatment of adults with immune TTP (iTTP) in combination with plasma exchange and immunosuppressive therapy. Represents the first […]
[…] prophylactic basis to patients deemed to be at high risk of an acute TTP relapse. Suggested dosing: 375 mg/m2 IV weekly for 4 weeks. Therapeutic plasma exchange […]
[…] a time series of CBCs from 2 patients. One of the patients has TTP, the other has Evans syndrome. Which is which, and why? Patient A […]
Systematic Reviews Related to TTP Soares Ferreira Junior A. Patient-Reported Outcome Measures in Patients with Thrombotic Thrombocytopenic Purpura: A Systematic Review of the Literature. J Clin […]